Published in Nucleic Acids Res on September 03, 2009
Human cellular restriction factors that target HIV-1 replication. BMC Med (2009) 1.86
Slicing tRNAs to boost functional ncRNA diversity. RNA Biol (2013) 1.68
Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology (2012) 1.62
Regulatory RNAs derived from transfer RNA? RNA (2010) 1.50
HIV-1 transcription and latency: an update. Retrovirology (2013) 1.49
Small RNAs derived from the 5' end of tRNA can inhibit protein translation in human cells. RNA Biol (2013) 1.43
tRNA fragments in human health and disease. FEBS Lett (2014) 1.41
tRNAs as regulators of biological processes. Front Genet (2014) 1.36
Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res (2011) 1.32
Exosomes derived from HIV-1-infected cells contain trans-activation response element RNA. J Biol Chem (2013) 1.31
Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell. J Virol (2011) 1.25
MicroRNAs and human retroviruses. Biochim Biophys Acta (2011) 1.23
In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. MBio (2013) 1.18
Absence of DICER in monocytes and its regulation by HIV-1. J Biol Chem (2010) 1.15
MicroRNAs and HIV-1: complex interactions. J Biol Chem (2012) 1.13
Hints of tRNA-Derived Small RNAs Role in RNA Silencing Mechanisms. Genes (Basel) (2012) 1.10
Transfer RNA as a source of small functional RNA. J Mol Biol Mol Imaging (2015) 1.08
Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding. J Virol (2010) 1.06
Host restriction factors in retroviral infection: promises in virus-host interaction. Retrovirology (2012) 1.05
RNAi in the regulation of mammalian viral infections. BMC Biol (2012) 1.04
Marek's disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway. J Virol (2010) 1.01
Coordinate roles of Gag and RNA helicase A in promoting the annealing of formula to HIV-1 RNA. J Virol (2010) 1.01
Tailored enrichment strategy detects low abundant small noncoding RNAs in HIV-1 infected cells. Retrovirology (2012) 1.01
Dissecting tRNA-derived fragment complexities using personalized transcriptomes reveals novel fragment classes and unexpected dependencies. Oncotarget (2015) 1.00
The HIV Nef protein modulates cellular and exosomal miRNA profiles in human monocytic cells. J Extracell Vesicles (2014) 0.99
The HIV-1 Nef protein binds argonaute-2 and functions as a viral suppressor of RNA interference. PLoS One (2013) 0.94
The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection. Virology (2013) 0.93
HIV-1-encoded antisense RNA suppresses viral replication for a prolonged period. Retrovirology (2012) 0.93
Exosomes from HIV-1-infected Cells Stimulate Production of Pro-inflammatory Cytokines through Trans-activating Response (TAR) RNA. J Biol Chem (2015) 0.90
MicroRNAs and their potential involvement in HIV infection. Trends Pharmacol Sci (2011) 0.90
A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box region. Retrovirology (2014) 0.89
HIV restriction in quiescent CD4⁺ T cells. Retrovirology (2013) 0.88
Replication competent HIV-1 viruses that express intragenomic microRNA reveal discrete RNA-interference mechanisms that affect viral replication. Cell Biosci (2011) 0.87
tRNA-Derived Fragments (tRFs): Emerging New Roles for an Ancient RNA in the Regulation of Gene Expression. Life (Basel) (2015) 0.86
Nucleoside modifications in the regulation of gene expression: focus on tRNA. Cell Mol Life Sci (2016) 0.85
MicroRNAs in HIV-1 infection: an integration of viral and cellular interaction at the genomic level. Front Microbiol (2012) 0.84
Complex role of microRNAs in HTLV-1 infections. Front Genet (2012) 0.83
Novel HIV-1 miRNAs stimulate TNFα release in human macrophages via TLR8 signaling pathway. PLoS One (2014) 0.83
tRNA-Derived Small Non-Coding RNAs in Response to Ischemia Inhibit Angiogenesis. Sci Rep (2016) 0.82
Functionally orthologous viral and cellular microRNAs studied by a novel dual-fluorescent reporter system. PLoS One (2012) 0.82
Localization and sub-cellular shuttling of HTLV-1 tax with the miRNA machinery. PLoS One (2012) 0.81
tRNA-Derived Short Non-coding RNA as Interacting Partners of Argonaute Proteins. Gene Regul Syst Bio (2015) 0.81
Alternative processing of the U2 small nuclear RNA produces a 19-22nt fragment with relevance for the detection of non-small cell lung cancer in human serum. PLoS One (2013) 0.80
Retrovirus infected cells contain viral microRNAs. Retrovirology (2013) 0.80
Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells. Virology (2015) 0.80
A comprehensive repertoire of tRNA-derived fragments in prostate cancer. Oncotarget (2016) 0.79
HIV-1 nef protein visits B-cells via macrophage nanotubes: a mechanism for AIDS-related lymphoma pathogenesis? Curr HIV Res (2010) 0.79
HLA-G/C, miRNAs, and their role in HIV infection and replication. Biomed Res Int (2013) 0.79
Biogenesis and Function of Transfer RNA-Related Fragments (tRFs). Trends Biochem Sci (2016) 0.79
tRNA-derived small RNAs target transposable element transcripts. Nucleic Acids Res (2017) 0.79
Profiling sex-specific piRNAs in zebrafish. Genetics (2010) 0.78
Beyond the Ribosome: Extra-translational Functions of tRNA Fragments. Biomark Insights (2016) 0.78
Update on non-canonical microRNAs. Biomol Concepts (2014) 0.78
Identification of human microRNA-like sequences embedded within the protein-encoding genes of the human immunodeficiency virus. PLoS One (2013) 0.77
Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development. J Gen Virol (2012) 0.77
tRF2Cancer: A web server to detect tRNA-derived small RNA fragments (tRFs) and their expression in multiple cancers. Nucleic Acids Res (2016) 0.77
Transcriptional Gene Silencing (TGS) via the RNAi Machinery in HIV-1 Infections. Biology (Basel) (2012) 0.77
MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations. Biomark Insights (2016) 0.77
HIV-1 RNAs are Not Part of the Argonaute 2 Associated RNA Interference Pathway in Macrophages. PLoS One (2015) 0.77
Mapping the small RNA content of simian immunodeficiency virions (SIV). PLoS One (2013) 0.77
Identification and characterization of piRNA-like small RNAs in the gonad of sea urchin (Strongylocentrotus nudus). Mar Biotechnol (NY) (2011) 0.76
HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs. RNA Biol (2015) 0.76
Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 Perspective. Leuk Res Treatment (2012) 0.76
Every little piece counts: the many faces of tRNA transcripts. Transcription (2015) 0.76
LTR-Retrotransposon Control by tRNA-Derived Small RNAs. Cell (2017) 0.76
The role of A-kinase anchoring protein 95-like protein in annealing of tRNALys3 to HIV-1 RNA. Retrovirology (2014) 0.75
Regulation of translation dynamic and neoplastic conversion by tRNA and their pieces. Translation (Austin) (2014) 0.75
Small Non-coding Transfer RNA-Derived RNA Fragments (tRFs): Their Biogenesis, Function and Implication in Human Diseases. Genomics Inform (2015) 0.75
MINTmap: fast and exhaustive profiling of nuclear and mitochondrial tRNA fragments from short RNA-seq data. Sci Rep (2017) 0.75
Dynamics of tRNA fragments and their targets in aging mammalian brain. F1000Res (2016) 0.75
The biogenesis pathway of tRNA-derived piRNAs in Bombyx germ cells. Nucleic Acids Res (2017) 0.75
Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89
An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science (2001) 44.16
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03
A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science (2001) 31.33
MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol (2005) 18.94
The microRNAs of Caenorhabditis elegans. Genes Dev (2003) 17.70
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell (2004) 16.10
Argonaute2, a link between genetic and biochemical analyses of RNAi. Science (2001) 15.32
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol (1988) 12.52
Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature (2008) 10.11
A cellular microRNA mediates antiviral defense in human cells. Science (2005) 8.48
MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev Cell (2007) 7.66
Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature (2007) 7.04
A piRNA pathway primed by individual transposons is linked to de novo DNA methylation in mice. Mol Cell (2008) 6.35
RNA sequence analysis defines Dicer's role in mouse embryonic stem cells. Proc Natl Acad Sci U S A (2007) 5.26
Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. Genome Res (2006) 5.23
An epigenetic role for maternally inherited piRNAs in transposon silencing. Science (2008) 5.05
Facile means for quantifying microRNA expression by real-time PCR. Biotechniques (2005) 5.04
Identification and characterization of two novel classes of small RNAs in the mouse germline: retrotransposon-derived siRNAs in oocytes and germline small RNAs in testes. Genes Dev (2006) 4.97
Processing of pre-microRNAs by the Dicer-1-Loquacious complex in Drosophila cells. PLoS Biol (2005) 4.93
L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol (2006) 4.80
Biogenesis and germline functions of piRNAs. Development (2007) 4.37
The microRNA world: small is mighty. Trends Biochem Sci (2003) 3.86
Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci U S A (2004) 3.85
Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity (2005) 3.70
Identification of novel and candidate miRNAs in rice by high throughput sequencing. BMC Plant Biol (2008) 3.43
Hidden layers of human small RNAs. BMC Genomics (2008) 3.31
MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Stem Cells (2008) 3.14
Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc Natl Acad Sci U S A (2008) 3.03
Cloning and expression of new microRNAs from zebrafish. Nucleic Acids Res (2006) 2.58
Viral and cellular messenger RNA targets of viral microRNAs. Nature (2009) 2.52
The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog (2007) 2.48
HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology (2004) 2.23
HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol (2007) 2.20
Structural insight into the mechanism of double-stranded RNA processing by ribonuclease III. Cell (2006) 2.15
RNA interference against viruses: strike and counterstrike. Nat Biotechnol (2007) 2.14
A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc Natl Acad Sci U S A (1996) 2.06
HIV-1 nef suppression by virally encoded microRNA. Retrovirology (2004) 2.05
Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res (2008) 2.03
MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology (2008) 1.96
Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology (2005) 1.95
Mouse microRNA profiles determined with a new and sensitive cloning method. Nucleic Acids Res (2006) 1.94
The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants. J Gen Virol (2004) 1.93
The roles of microRNAs in mammalian virus infection. Biochim Biophys Acta (2008) 1.64
Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J Gen Virol (2005) 1.46
HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1. Proc Natl Acad Sci U S A (2009) 1.39
HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology (2009) 1.35
Transcriptional regulation of early transposon elements, an active family of mouse long terminal repeat retrotransposons. J Virol (2005) 1.35
Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Gastroenterology (2006) 1.31
New roles for large and small viral RNAs in evading host defences. Nat Rev Genet (2008) 1.31
Requirement for Sun1 in the expression of meiotic reproductive genes and piRNA. Development (2009) 1.30
The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference. Retrovirology (2006) 1.20
HIV-1 Tat interaction with Dicer: requirement for RNA. Retrovirology (2006) 1.20
RNAi suppressors encoded by pathogenic human viruses. Int J Biochem Cell Biol (2008) 1.18
A story with a good ending: tRNA 3'-end maturation by CCA-adding enzymes. Curr Opin Struct Biol (2005) 1.14
Role of post-transcriptional modifications of primer tRNALys,3 in the fidelity and efficacy of plus strand DNA transfer during HIV-1 reverse transcription. J Biol Chem (1999) 1.14
The NS3 protein of rice hoja blanca virus complements the RNAi suppressor function of HIV-1 Tat. EMBO Rep (2009) 1.13
Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions? Retrovirology (2007) 1.12
siRNA, miRNA and HIV: promises and challenges. Cell Res (2005) 1.09
Inhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primer-binding site. J Virol (2006) 1.07
Molecular analysis of the second template switch during reverse transcription of the HIV RNA template. Biochemistry (1996) 1.03
Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus. J Gen Virol (2008) 1.01
HCV core protein interacts with Dicer to antagonize RNA silencing. Virus Res (2008) 1.01
Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site. Virology (2004) 0.92
In vitro studies on tRNA annealing and reverse transcription with mutant HIV-1 RNA templates. J Biol Chem (2000) 0.86
The properties and functions of virus encoded microRNA, siRNA, and other small noncoding RNAs. Crit Rev Microbiol (2008) 0.85
Mustering the micromanagers. Nat Biotechnol (2007) 0.82
The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol (2007) 8.98
Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science (2007) 5.07
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer (2007) 4.69
Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One (2008) 4.24
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A (2007) 4.04
Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell (2004) 3.73
Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity (2005) 3.70
Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol Syst Biol (2010) 3.56
Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a 'safety belt' binding mechanism for the spindle checkpoint. EMBO J (2002) 3.42
Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene (2005) 2.96
Impact factor, H index, peer comparisons, and Retrovirology: is it time to individualize citation metrics? Retrovirology (2007) 2.87
A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem (2009) 2.40
HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology (2004) 2.23
Accumulation of the inner nuclear envelope protein Sun1 is pathogenic in progeric and dystrophic laminopathies. Cell (2012) 2.18
Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res (2007) 1.96
MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology (2008) 1.96
Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology (2005) 1.95
Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. J Hepatol (2006) 1.89
Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation. EMBO J (2008) 1.87
Human cellular restriction factors that target HIV-1 replication. BMC Med (2009) 1.86
A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat Cell Biol (2003) 1.82
Diverse effects of cyclosporine on hepatitis C virus strain replication. J Virol (2006) 1.72
The roles of microRNAs in mammalian virus infection. Biochim Biophys Acta (2008) 1.64
Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res (2008) 1.63
Viral and cellular RNA helicases as antiviral targets. Nat Rev Drug Discov (2005) 1.59
NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression. MBio (2013) 1.55
Suppression of HIV-1 replication by microRNA effectors. Retrovirology (2009) 1.44
HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J Biol Chem (2006) 1.35
Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein. Mol Cell Biol (2002) 1.34
RISCy business: MicroRNAs, pathogenesis, and viruses. J Biol Chem (2007) 1.32
Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811. Biochem Biophys Res Commun (2006) 1.32
Transcriptional and post-transcriptional regulation of HIV-1 gene expression: role of cellular factors for Tat and Rev. Future Microbiol (2006) 1.32
Histone acetyltransferase hALP and nuclear membrane protein hsSUN1 function in de-condensation of mitotic chromosomes. J Biol Chem (2007) 1.31
Requirement for Sun1 in the expression of meiotic reproductive genes and piRNA. Development (2009) 1.30
Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes. J Biol Chem (2009) 1.29
FAT10 plays a role in the regulation of chromosomal stability. J Biol Chem (2006) 1.28
Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF. EMBO J (2002) 1.27
Human T-lymphotropic virus type I tax activates I-kappa B kinase by inhibiting I-kappa B kinase-associated serine/threonine protein phosphatase 2A. J Biol Chem (2002) 1.25
HTLV-1 Tax and adult T-cell leukemia. Front Biosci (2007) 1.25
Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression. J Virol (2011) 1.25
Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein. Proc Natl Acad Sci U S A (2005) 1.24
Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors. J Biol Chem (2001) 1.23
MicroRNAs and human retroviruses. Biochim Biophys Acta (2011) 1.23
The LINC complex is essential for hearing. J Clin Invest (2013) 1.22
Ubiquitination of human T-cell leukemia virus type 1 tax modulates its activity. J Virol (2004) 1.22
Ubiquitin-specific peptidase 20 targets TRAF6 and human T cell leukemia virus type 1 tax to negatively regulate NF-kappaB signaling. J Virol (2011) 1.21
H-index, mentoring-index, highly-cited and highly-accessed: how to evaluate scientists? Retrovirology (2008) 1.20
HIV-1 Tat interaction with Dicer: requirement for RNA. Retrovirology (2006) 1.20
Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1. J Biol Chem (2002) 1.19
Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem (2010) 1.19
Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication. J Med Chem (2008) 1.17
25 years of HIV-1 research - progress and perspectives. BMC Med (2008) 1.17
Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein. J Biol Chem (2006) 1.17
TORC1 and TORC2 coactivators are required for tax activation of the human T-cell leukemia virus type 1 long terminal repeats. J Virol (2006) 1.17
Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction. Proc Natl Acad Sci U S A (2012) 1.16
Aneuploidy and cancer. J Cell Biochem (2007) 1.16
Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance. J Biol Chem (2012) 1.16
MicroRNAs and HIV-1: complex interactions. J Biol Chem (2012) 1.13
Spindle assembly checkpoint and p53 deficiencies cooperate for tumorigenesis in mice. Int J Cancer (2009) 1.12
Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions? Retrovirology (2007) 1.12
Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol Res (2006) 1.12
Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication. J Biol Chem (2003) 1.11
Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. J Biol Chem (2011) 1.11
The 2008 Retrovirology Prize: Ben Berkhout and his RNA world. Retrovirology (2008) 1.10
Differential requirements for activation of integrated and transiently transfected human T-cell leukemia virus type 1 long terminal repeat. J Virol (2002) 1.10
An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection. J Biol Chem (2003) 1.09
Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factor-beta signaling by blocking the association of Smad proteins with Smad-binding element. J Biol Chem (2002) 1.09
siRNA, miRNA and HIV: promises and challenges. Cell Res (2005) 1.09
Retrovirology and young Turks... Retrovirology (2004) 1.09
Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1. J Virol (2005) 1.08
Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics (2005) 1.07
Genome-wide screening using RNA interference to study host factors in viral replication and pathogenesis. Exp Biol Med (Maywood) (2011) 1.07
When is it time for reverse transcription to start and go? Retrovirology (2009) 1.07
Libya, HIV, and open communication. Retrovirology (2006) 1.07
Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor. Cancer Sci (2009) 1.07
RNA-binding protein HuR interacts with thrombomodulin 5'untranslated region and represses internal ribosome entry site-mediated translation under IL-1 beta treatment. Mol Biol Cell (2008) 1.07
Human T-cell leukemia virus oncoprotein tax represses nuclear receptor-dependent transcription by targeting coactivator TAX1BP1. Cancer Res (2007) 1.07
MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes. Hepatology (2010) 1.07
Stability of a long noncoding viral RNA depends on a 9-nt core element at the RNA 5' end to interact with viral ORF57 and cellular PABPC1. Int J Biol Sci (2011) 1.06
The young, not-so-young, and the 2007 Retrovirology Prize: call for nominations. Retrovirology (2007) 1.06
Host restriction factors in retroviral infection: promises in virus-host interaction. Retrovirology (2012) 1.05
Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expression. Retrovirology (2011) 1.04
Segregation of NF-kappaB activation through NEMO/IKKgamma by Tax and TNFalpha: implications for stimulus-specific interruption of oncogenic signaling. Oncogene (2003) 1.04
Human T-cell leukemia virus type 1 Tax and cellular transformation. Int J Hematol (2007) 1.04
The highly structured encapsidation signal of MuLV RNA is involved in the nuclear export of its unspliced RNA. J Mol Biol (2005) 1.02
Expression of a protein phosphatase 1 inhibitor, cdNIPP1, increases CDK9 threonine 186 phosphorylation and inhibits HIV-1 transcription. J Biol Chem (2010) 1.02
The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat Cell Biol (2006) 1.02
Inactivation of hTERT transcription by Tax. Oncogene (2003) 1.01
Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1. J Virol (2008) 1.00
Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs. Proc Natl Acad Sci U S A (2010) 0.99
Long non-coding RNAs (lncRNAs) and viral infections. Biomed Pharmacother (2013) 0.98
Characterization of regions in hsMAD1 needed for binding hsMAD2. A polymorphic change in an hsMAD1 leucine zipper affects MAD1-MAD2 interaction and spindle checkpoint function. J Biol Chem (2002) 0.98
Specific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complex. Retrovirology (2004) 0.98